- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Lennox-Gastaut syndrome
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 696KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 122KB)
Cannabidiol – March 2022
Cannabidiol: Oral liquid 100 mg per mL, 100 mL; Epidyolex®
Last updated
1 July 2022